Today: 9 June 2026
XRP Price Today: Ripple Token Rebounds Near $1.34, but Leverage and Crypto Bill Risks Keep Pressure On
30 March 2026
2 mins read

XRP Price Today: Ripple Token Rebounds Near $1.34, but Leverage and Crypto Bill Risks Keep Pressure On

NEW YORK, March 30, 2026, 14:13 EDT

XRP saw a slight uptick Monday, changing hands near $1.34 after briefly dropping to $1.30 on Sunday. The move wasn’t dramatic, holding the Ripple-associated token within a narrow range. Over the last 24 hours, XRP’s price swung between $1.326 and $1.364.

XRP is holding onto its spot as the fifth-biggest cryptocurrency, sporting a market cap near $81.8 billion. Yet, that’s still about 63% off its July 2025 high of $3.65. The recent rebound has offered a bit of relief, though the broader outlook stays the same.

Broader crypto sentiment is still on shaky ground. Bitcoin and ether edged higher Monday, with markets attempting to steady after another round of turbulence linked to the Middle East conflict. But Nexo’s Iliya Kalchev described crypto as being stuck in “wait-and-see” mode—traders are holding their ground rather than jumping into new bets. Reuters

Right now, that’s important: money is heading out of crypto investment products just as U.S. policy discussions get more tangled. Crypto funds saw $414 million in outflows last week, snapping a five-week streak of inflows. James Butterfill, research chief at CoinShares, said the retreat was “likely related to the Clarity Act news”— the U.S. bill aimed at clarifying digital asset regulation. Decrypt

XRP derivatives point to traders sticking with leverage. On Monday, open interest hovered near $2.55 billion. Futures turnover clocked in at approximately $3.40 billion, with liquidations—forced close-outs—reaching about $6.4 million.

On Sunday, CoinDesk flagged XRP hovering at $1.33, spotlighting a surge in funding and a rash of liquidations — evidence of traders stacking up bets behind the scenes. Funding rates, those periodic transfers tied to perpetual futures, saw sharp moves; when those climb but spot prices barely budge, things can unravel quickly.

Ripple CEO Brad Garlinghouse isn’t letting the regulatory debate slip out of sight. Over the weekend, he described talks on the Clarity Act as “not been pretty,” yet said a breakthrough was near, with the bill potentially finalized by the end of May. DL News

XRP’s price action remains tethered to regulatory headlines out of Washington, just as much as to anything coming from Ripple or its network. The SEC wrapped up its suit against Ripple in August 2025—Ripple agreed to a $125 million penalty—but despite that resolution, the token hasn’t managed to climb back to last year’s peaks.

The risk stands out: Should bitcoin take another hit, or if lawmakers fumble the bill further, XRP’s Monday rally could evaporate fast. Leverage remains elevated, so any pullback—no matter how minor—might trigger additional selling pressure. That’s based on the way traders are set up right now and the latest fund-flow numbers, not a directional forecast.

XRP isn’t showing much in the way of breakout energy yet. After rebounding from the weekend’s low, it’s hanging in the low-$1.30s, but bulls haven’t managed more than holding the line so far. This remains a recovery narrative, not a clear exit from pressure.

Stock Market Today

  • SailPoint Q1 Earnings Beat Estimates Amid Revenue Growth
    June 9, 2026, 10:14 AM EDT. SailPoint, Inc. (SAIL) reported Q1 earnings of $0.05 per share, surpassing the Zacks Consensus Estimate of $0.04 by 17.65%. Revenue increased to $280.14 million, beating estimates by 1.41% and up from $230.47 million a year ago. Despite earnings surprises and revenue growth, SailPoint shares have declined 12.6% year-to-date against the S&P 500's 8.2% rise. The company holds a Zacks Rank #3 (Hold), indicating expected market-aligned performance. Consensus estimates forecast Q2 EPS of $0.08 on $310.79 million revenue and fiscal year EPS of $0.32 on $1.27 billion revenue. Industry trends in the Zacks Internet-Software sector will influence future stock performance. Investors await management's commentary for guidance on sustainability.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Dow Jones Index Today: Dow Jumps 300 Points as Wall Street Tries to Shake Off Correction
Previous Story

Dow Jones Index Today: Dow Jumps 300 Points as Wall Street Tries to Shake Off Correction

Oracle Stock’s AI Bet Faces Fresh Test as Dividend Fears Clash With New Bull Call
Next Story

Oracle Stock’s AI Bet Faces Fresh Test as Dividend Fears Clash With New Bull Call

Go toTop